
-
SFWJ / Medcana Announces Strategic Expansion Into Australia With Acquisition of Cannabis Import and Distribution Licenses
-
Frankfurt's Goetze sidelined with leg injury
-
Spurs players 'never lost belief', says Postecoglou
-
Man Utd stun Lyon in nine-goal Europa League classic to reach semis
-
Netflix earnings in first quarter of 2025 top forecasts
-
Trump says US 'talking' to China on tariffs
-
Salvadoran soldiers stop US senator near prison holding expelled migrant
-
Solanke penalty sends Spurs to Europa League semis
-
CAF crackdown after trouble in African club matches
-
Trump talks up EU tariff deal as Italy's Meloni visits
-
Trump insists he could fire independent Fed Chair Powell
-
Google has illegal monopoly in ad tech, US judge rules
-
Trump softens on Zelensky, says mineral deal coming 'soon'
-
Jacks helps Mumbai beat Hyderabad in IPL
-
Countries must 'make the best' of new multipolar world: IMF chief
-
Heavy spring snow storm wreaks havoc in the Alps
-
US judge rules against Google in online ad tech antitrust case
-
Andreeva knocked out by Alexandrova in Stuttgart last 16
-
Iran challenges four countries in UN court over jet it downed in 2020
-
'Not at 50' - Alonso sets retirement limit
-
Macron praises US-European-Ukraine talks as 'important occasion for convergence'
-
Verstappen dismisses Red Bull exit fears
-
Italy's Meloni, Trump talk up EU trade deal hopes
-
'Slow but steady' progress for Martin after Qatar MotoGP crash
-
Pogacar-Van der Poel duel inspires Evenepoel comeback
-
US judge rules Google monopolized online ad tech market
-
Bearman back at 'special' debut-track Jeddah
-
Swiss watch exports to US soared ahead of Trump tariffs
-
Alcaraz finds best to reach Barcelona Open quarters
-
Where are all the aliens?: Fermi's Paradox explained
-
France full-back Dulin to retire at end of season
-
World economy likely to avoid recession despite tariffs: IMF chief
-
57 killed in Sudan's Darfur as trapped civilians fear bloodbath
-
Vietnam ups wind, solar targets as energy demand soars
-
Pope says doing 'best he can' on jail visit before Easter
-
China's Xi meets Cambodian leader as part of regional diplomatic blitz
-
Ukrainian tennis player seeks legal justice over 'moral abuse'
-
Italy's Meloni seeks EU tariff deal from Trump
-
France's feminist icon Pelicot to sue Paris Match for privacy invasion
-
World economy should avoid recession despite tariffs, IMF chief says
-
Stocks waver as ECB cuts rate, Trump slams Fed chief
-
France, UK mull migrant swaps in bid to stem Channel crossings
-
Nuno says Forest still in control of Champions League chase
-
Malinin, Liu help US take early lead at skating's World Team Trophy
-
Clashes in Sudan's besieged Darfur city kill 57
-
Kyiv's Europe allies seek influence with US in Paris talks
-
Russia scraps Taliban's 'terror' label amid warming ties
-
Trump says Fed chief's 'termination cannot come fast enough'
-
China's Xi, seeking to build regional ties, meets Cambodian leader
-
ECB cuts rates as Trump tariffs raise fears for eurozone growth

New Mexico Governor Signs Bill Allowing for Psilocybin Use
‘Medical Psilocybin Act' Provides Legal Access to Citizens for the First Time
LAS VEGAS, NV / ACCESS Newswire / April 9, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that New Mexico governor Michelle Lujan signed SB 219, the Medical Psilocybin Act, which will establish the third state-legal psilocybin access system in the United States.
The Medical Psilocybin Act will provide patients with specific qualifying conditions to obtain the psychedelic and to use it under the guidance of a licensed healthcare provider.
"Today is another watershed event for functional mushrooms and the growing acceptance of their practical use in an array of applications," stated Hypha Labs Chief Executive Officer, Stone Douglass. "And it is long overdue."
"As we embark on our journey to create the first device of its kind which will truly democratize mushroom ingredient production by allowing an individual to produce their desired 'crops' in predictable eight day cycles from the privacy and comfort of home, transformative events like this both affirm our mission and expand our market."
"We believe as the legislative dominoes fall that other jurisdictions will see the successes in places like New Mexico as a template for their own jurisdictions," added Douglass.
"We are at a tipping point."
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity MediaInc.
(888) 216-3595
[email protected]
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire
D.Kaufman--AMWN